These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11297518)

  • 21. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
    Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
    Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.
    Toi M; Harris AL; Bicknell R
    Br J Cancer; 1993 Dec; 68(6):1088-96. PubMed ID: 8260359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer.
    Osipo C; Gajdos C; Liu H; Chen B; Jordan VC
    J Natl Cancer Inst; 2003 Nov; 95(21):1597-608. PubMed ID: 14600092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
    Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
    Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein.
    Pink JJ; Jiang SY; Fritsch M; Jordan VC
    Cancer Res; 1995 Jun; 55(12):2583-90. PubMed ID: 7780972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE
    Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen regulation of thrombospondin-1 in human breast cancer cells.
    Hyder SM; Liang Y; Wu J
    Int J Cancer; 2009 Sep; 125(5):1045-53. PubMed ID: 19391135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
    Takei H; Lee ES; Jordan VC
    Breast Cancer; 2002; 9(1):39-42. PubMed ID: 12196720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
    Sommer A; Hoffmann J; Lichtner RB; Schneider MR; Parczyk K
    J Steroid Biochem Mol Biol; 2003 May; 85(1):33-47. PubMed ID: 12798355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L; Kharbanda S; Hanfelt J; Kern FG
    Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans.
    Chen N; Chen CC; Lau LF
    J Biol Chem; 2000 Aug; 275(32):24953-61. PubMed ID: 10821835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
    Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.
    Fernandez-Cuesta L; Anaganti S; Hainaut P; Olivier M
    Int J Cancer; 2011 Apr; 128(8):1813-21. PubMed ID: 20549698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.